BIIB
$333.00
Biogen
$.13
.04%
Earnings Details
4th Quarter December 2018
Tweet Share Watch
Summary

Biogen Beats

Biogen (BIIB) reported 4th Quarter December 2018 earnings of $6.99 per share on revenue of $3.5 billion. The consensus earnings estimate was $6.72 per share on revenue of $3.4 billion. The Earnings Whisper number was $6.83 per share. Revenue grew 6.6% on a year-over-year basis.

Biogen Idec Inc, is a biopharmaceutical company. The Company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.

Results
Reported Earnings
$6.99
Earnings Whisper
$6.83
Consensus Estimate
$6.72
Reported Revenue
$3.53 Bil
Revenue Estimate
$3.39 Bil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release